Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 34.55%13.87B | 39.09%15.58B | 2.42%10.99B | 7.04%43.3B | 10.95%11.06B | 4.33%10.31B | 10.90%11.2B | 2.16%10.73B | 10.20%40.46B | 5.54%9.97B |
Cost of revenue | 33.47%8.16B | 44.41%9.35B | 1.46%6B | 9.03%25.22B | 17.71%6.72B | 3.69%6.11B | 14.97%6.47B | 0.28%5.92B | 16.78%23.14B | 7.67%5.71B |
Gross profit | 36.11%5.71B | 31.82%6.23B | 3.61%4.99B | 4.39%18.08B | 1.90%4.34B | 5.28%4.2B | 5.78%4.73B | 4.57%4.81B | 2.50%17.32B | 2.81%4.26B |
Operating expense | 42.35%3.96B | 54.17%4.42B | 10.33%2.94B | 6.51%11.42B | 4.04%3.1B | 5.42%2.78B | 8.59%2.87B | 8.42%2.67B | -3.01%10.72B | -3.68%2.98B |
Operating profit | 23.87%1.76B | -2.66%1.81B | -4.73%2.04B | 0.94%6.66B | -3.10%1.24B | 4.99%1.42B | 1.71%1.86B | 0.14%2.15B | 12.91%6.6B | 21.94%1.28B |
Net non-operating interest income (expenses) | 86.45%2.26M | -127.63%-399K | -8.85%1.33M | 36.69%5.39M | -2.66%1.28M | -3.35%1.21M | 141.47%1.44M | 86.92%1.46M | 16.76%3.94M | 47.14%1.31M |
Non-operating interest income | 83.32%2.28M | -23.02%1.14M | -9.62%1.35M | 30.06%5.53M | -3.76%1.31M | -5.19%1.24M | 115.89%1.48M | 67.08%1.5M | 2.68%4.25M | 57.61%1.36M |
Non-operating interest expense | -38.71%19K | 4,059.46%1.54M | -38.46%24K | -55.92%134K | -37.21%27K | -45.61%31K | -57.95%37K | -66.38%39K | -59.95%304K | 234.38%43K |
Net investment income | -820.37%-56.54M | -64.79%28.37M | 107.26%71.22M | 0.68%85.89M | 70.61%-36.88M | -89.81%7.85M | -4.02%80.56M | -31.04%34.36M | -60.54%85.31M | -584.48%-125.46M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 146.79M | 0 | ||||||||
Income from associates and other participating interests | 270.77%7.35M | 249.48%19.61M | 74.65%-4.84M | -3.4M | 32.86%14.37M | 6.62%-4.3M | -25.78%5.61M | -38.55%-19.08M | 0 | -34.29%10.81M |
Special income (charges) | 100.07%6K | 98.80%-27K | 104.68%8.39M | 95.31%-7.6M | -187.99%-1.09M | 90.40%-8.35M | 96.77%-2.26M | 162.88%4.1M | -36.38%-162.18M | 101.43%1.24M |
Less:Other special charges | -100.07%-6K | -98.80%27K | -104.68%-8.39M | -95.31%7.6M | 187.99%1.09M | -90.40%8.35M | -96.77%2.26M | -162.88%-4.1M | 144.95%162.18M | -134.77%-1.24M |
Other non-operating income (expenses) | 31.45%4.84M | 155.43%11.52M | 131.13%13.22M | -51.60%4.46M | 212.52%15.84M | -81.59%3.68M | -9,462.16%-20.78M | 85.95%5.72M | -77.62%9.21M | -215.57%-14.08M |
Income before tax | 20.89%1.71B | -2.86%1.87B | -1.79%2.13B | 5.47%6.89B | 19.66%1.38B | 4.48%1.42B | 3.97%1.92B | -0.17%2.17B | 9.07%6.54B | 24.46%1.15B |
Income tax | 26.93%638.14M | 1.25%684.08M | -5.30%715.25M | 14.59%2.43B | 94.80%499.65M | 47.28%502.74M | -0.07%675.64M | -11.10%755.3M | -7.90%2.12B | -23.10%256.49M |
Net income | 17.57%1.07B | -5.08%1.19B | 0.09%1.42B | 1.08%4.46B | -1.82%880.62M | -9.91%914.21M | 6.29%1.25B | 6.82%1.42B | 19.68%4.41B | 51.20%896.96M |
Net income continuous operations | 17.57%1.07B | -5.08%1.19B | 0.09%1.42B | 1.08%4.46B | -1.82%880.62M | -9.91%914.21M | 6.29%1.25B | 6.82%1.42B | 19.68%4.41B | 51.20%896.96M |
Noncontrolling interests | 45.87%31.27M | 31.15%26.75M | -0.76%26.8M | 36.17%92.66M | 21.64%23.83M | 55.04%21.43M | 47.62%20.4M | 29.71%27M | 8.44%68.05M | 12.62%19.59M |
Net income attributable to the company | 16.89%1.04B | -5.68%1.16B | 0.10%1.39B | 0.53%4.37B | -2.35%856.79M | -10.81%892.78M | 5.80%1.23B | 6.46%1.39B | 19.87%4.35B | 52.36%877.37M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 16.89%1.04B | -5.68%1.16B | 0.10%1.39B | 0.53%4.37B | -2.35%856.79M | -10.81%892.78M | 5.80%1.23B | 6.46%1.39B | 19.87%4.35B | 52.36%877.37M |
Gross dividend payment | ||||||||||
Basic earnings per share | 13.13%43.68 | 3.14%48.67 | 10.50%58.84 | 10.23%175.79 | 8.28%36.74 | 6.31%38.61 | 11.88%47.19 | 13.18%53.25 | 22.15%159.48 | 64.15%33.93 |
Diluted earnings per share | 13.22%43.68 | 3.33%48.47 | 10.70%58.57 | 10.44%175.01 | 8.19%36.61 | 6.99%38.58 | 12.04%46.91 | 13.30%52.91 | 22.30%158.47 | 64.03%33.84 |
Dividend per share | 0 | 16.67%28 | 0 | 10.42%53 | 16.00%29 | 0 | 4.35%24 | 0 | 20.00%48 | 19.05%25 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |